Avtor/Urednik     Kragelj, Borut; Zaletel-Kragelj, Lijana
Naslov     Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer
Tip     članek
Vir     Radiother Oncol
Vol. in št.     Letnik 102, št. 3
Leto izdaje     2012
Obseg     str. 412-5
Jezik     eng
Abstrakt     Tolerability to gemcitabine radiochemotherapy was evaluated in 33 patients with inoperable, locally advanced transitional-cell bladder cancers. The dose of 75 mg/m2 gemcitabine once a week, concurrently with standard radiotherapy of 60 Gy/6 weeks, was found to be acceptable. Eighty-one percentage of 3-year local progression-free survival suggests efficiency warranting further studies.
Deskriptorji     BLADDER NEOPLASMS